Hubei Biocause Pharmaceutical Co Ltd. Stock Analysis 000627.SZ

Hubei Biocause Pharmaceutical Co., Ltd. is an investment holding company that engages in the insurance industry. The company is headquartered in Jingmen, Hubei and currently employs 1,765 full-time employees. The firm is also engaged in fund sales business. The firm mainly operates through three segments. The Life Insurance Business segment refers to the Company's life insurance policy-related business, including original insurance contracts and life insurance policies that have not transferred significant insurance risks. The Accident and Health Insurance Business segment refers to the Company's accident and health insurance policy-related business, including original insurance contracts and health insurance policies that have not transferred significant insurance risks. The Other Business segment refers to the Company's other business except life insurance policies.